The association between antithrombotics and stroke risk*
| Antithrombotic type | Ischaemic stroke | Haemorrhagic stroke | ||||||
| No (N=7862) | Yes (N=448) | aHR* (95% CI) | P value | No (N=8195) N (%) | Yes (N=115) N (%) | aHR* (95% CI) | P value | |
| N (%) | N (%) | |||||||
| Antiplatelet | 1741 (22.1) | 169 (37.7) | 2.02 (1.66 to 2.45) | <0.001 | 1947 (23.8) | 40 (34.8) | 1.74 (1.18 to 2.57) | 0.005 |
| Anticoagulant | 238 (3.0) | 33 (7.4) | 2.56 (1.79 to 3.66) | <0.001 | 278 (3.4) | 7 (6.1) | 2.00 (0.91 to 4.20) | 0.086 |
| Antithrombotic | 1862 (23.7) | 180† (40.2) | 2.06 (1.70 to 2.49) | <0.001 | 2080 (25.4) | 43‡ (37.4) | 1.79 (1.22 to 2.63) | 0.003 |
*Adjusted for age, gender, CCI, and urbanisation level.
†In total, 22 patients used both anticoagulants and antiplatelets.
‡Four patients used both anticoagulants and antiplatelets.